Logo image of CERE

CEREVEL THERAPEUTICS HOLDING (CERE) Stock Analyst Ratings

NASDAQ:CERE - Nasdaq - US15678U1280 - Common Stock - Currency: USD

44.96  +0.33 (+0.74%)

After market: 44.97 +0.01 (+0.02%)

Buy % Consensus

53

ChartMill assigns a Buy % Consensus number of 53% to CERE. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 44.27. This target is -1.54% below the current price.
CERE was analyzed by 14 analysts. The buy percentage consensus is at 53. So analysts seem to be rather neutral about CERE.
In the previous month the buy percentage consensus was at a similar level.
CERE was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
CERE Historical Analyst RatingsCERE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -45 -41 -37 -33 -29 -25 -21 -17 -13 -9 -5 -1 5 10 15

Price Target & Forecast

Price Low Median Mean High 44.9631.3145.9044.2747.25 - -30.36% 2.09% -1.54% 5.09%
CERE Current Analyst RatingCERE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2024-02-16 Mizuho Maintains Neutral -> Neutral
2023-12-28 JP Morgan Maintains Neutral -> Neutral
2023-12-22 Jefferies Downgrade Buy -> Hold
2023-12-08 TD Cowen Downgrade Outperform -> Market Perform
2023-12-07 Cantor Fitzgerald Downgrade Overweight -> Neutral
2023-12-07 Piper Sandler Downgrade Overweight -> Neutral
2023-12-07 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-11-20 JP Morgan Reiterate Neutral
2023-11-02 Morgan Stanley Maintains Overweight -> Overweight
2023-09-28 Piper Sandler Initiate Overweight
2023-08-07 Mizuho Maintains Neutral -> Neutral
2023-08-03 B of A Securities Downgrade Buy -> Neutral
2023-08-03 Morgan Stanley Maintains Overweight -> Overweight
2023-08-03 HC Wainwright & Co. Maintains Buy -> Buy
2023-05-23 Goldman Sachs Maintains Neutral -> Neutral
2023-05-08 Mizuho Maintains Neutral
2023-05-04 Wells Fargo Upgrade Equal-Weight -> Overweight
2023-04-10 TD Cowen Initiate Outperform
2023-04-03 HC Wainwright & Co. Reiterate Buy
2023-03-17 JP Morgan Downgrade Overweight -> Neutral
2023-03-16 Berenberg Reiterate Hold
2023-03-09 Mizuho Maintains Neutral
2023-02-23 Wells Fargo Downgrade Overweight -> Equal-Weight
2023-02-23 Morgan Stanley Maintains Overweight
2023-02-23 HC Wainwright & Co. Maintains Buy
2022-12-06 JP Morgan Maintains Overweight
2022-11-10 Mizuho Maintains Neutral
2022-11-09 HC Wainwright & Co. Maintains Buy
2022-11-01 Loop Capital Initiate Buy
2022-10-20 B of A Securities Initiate Buy